U.S. doctors reconsider Pfizer’s Paxlovid for lower-risk COVID patients
May 28 (Reuters) – Use of Pfizer Inc’s (PFE.N) COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can […]